Prognostic model of patients with liver cancer based on tumor stem cell content and immune process
Figure 6.(A) QPCR analysis of KLHL30 and PLN in normal liver cell line and LIHC cell line (n = 3, ***P < 0.001, paired t test. (B–D) IHC results related to significant genes. (E) Nonparametric test (U test) for continuous variables and risk groups in the training set; P < 0.05 represents significant difference. (F) U test for continuous variables and risk groups in the test set; P < 0.05 represents significant difference. (G and H) Chi-square test for discrete variables and risk groups. (G) Training set. (H) Test sets. P < 0.05 represents a significant difference.